Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediates Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112041298A details a safe, efficient route for aromatic nitriles via Willgerodt rearrangement. Reduces sulfur impurities and avoids toxic cyanides for pharma intermediates.
Novel method for 4-aminoazaindole ketones via rearrangement and oxidation-reduction. Offers mild conditions and high purity for drug discovery.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Patent CN111349014A reveals a safer, high-yield route for Methyl (methylamino)squarate, eliminating hazardous solvents and reducing manufacturing costs for global supply chains.
Patent CN108383876B reveals a novel strained-ring phosphorus catalyst enabling efficient intramolecular Wittig reactions with reduced costs and simplified supply chains for fine chemical manufacturing.
Analysis of CN103570562A reveals a novel chiral Ni complex offering high conversion in Henry reactions. Discover cost-effective catalytic solutions for pharmaceutical manufacturing.
Patent CN103342710A details a novel chiral zinc complex for asymmetric cyanosilylation, offering a scalable, cost-effective solution for high-purity pharmaceutical intermediate manufacturing.
Patent CN113135831A reveals a safer 2-step synthesis for alminoprofen intermediates, eliminating Raney nickel risks and significantly reducing industrial waste generation.
Patent CN101260062B reveals a robust route for beta-aminopropenones, offering high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN101260062A details a high-yield route for beta-aminopropenones using formate esters, offering cost-effective API intermediate manufacturing solutions.
Patent CN113387799A reveals a novel TiCl4-catalyzed cross-coupling method using alcohols instead of toxic halides, offering significant cost reduction and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN106946923A reveals a transition-metal-free synthesis route for 1,2-diboron compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113831242A reveals a room-temperature synthesis route for Dolutegravir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN1823074A details a chromatography-free route for bicyclic heteroaryl aldehydes. Discover cost-effective manufacturing and high-purity pharmaceutical intermediates.
Patent CN112094205A reveals a safer liquid-phase synthesis for Fmoc-Ser(tBu)-OH, offering high chiral purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114957044B details a novel synthesis route preventing polycondensation. Offers high purity and scalable manufacturing for global polypeptide supply chains.